US 12161607
Combination of cannabinoids in the treatment of leukemia
granted A61KA61K31/05A61K31/352
Quick answer
US patent 12161607 (Combination of cannabinoids in the treatment of leukemia) held by JAZZ PHARMACEUTICALS RESEARCH UK LIMITED expires Mon Dec 05 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- JAZZ PHARMACEUTICALS RESEARCH UK LIMITED
- Grant date
- Tue Dec 10 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 05 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 16
- CPC classes
- A61K, A61K31/05, A61K31/352, A61K31/475, A61K31/658